Soy
A well-studied whole food and supplement category. Soy protein at ~25 g/day modestly lowers LDL cholesterol (3–4%), and high-genistein isoflavone supplements modestly reduce hot flushes. Modern evidence does NOT support the 'soy causes breast cancer' fear — it's neutral or modestly protective in survivors and the general population.
Quick decision guide
May help most
Adults wanting a modest LDL reduction from a plant-protein source, and menopausal women trialing high-genistein isoflavones for hot flushes before considering hormone therapy.
Common dosing range
25 g/day soy protein for cholesterol; 40–80 mg/day isoflavones (with ≥18.8 mg genistein) for hot flushes.
When to expect effects
Weeks for LDL; 8–12 weeks for hot-flush effect to plateau.
Watch out for
Soy can interfere with levothyroxine absorption — separate by 4 hours. Lab/animal data hint at antagonism with tamoxifen/aromatase inhibitors, but clinical impact in survivors is not demonstrated.
Evidence snapshot
What is it
Soy (Glycine max) is a leguminous oilseed in the Fabaceae family supplying high-quality protein (~36% by dry weight), polyunsaturated oil, and the isoflavone phytoestrogens genistein, daidzein, and glycitein. Supplements are sold as whole-bean protein isolates, fermented forms (natto, tempeh extracts), or standardized isoflavone concentrates.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
LDL cholesterol reduction (soy protein) Good Evidence | LDL-C −4.76 mg/dL (≈3.2%); total cholesterol −6.41 mg/dL (≈2.8%) at 25 g/day soy protein | Adults with borderline-elevated LDL who can sustain ~25 g/day soy protein as part of a plant-forward diet | ≈6 weeks to see effect; sustained as long as intake continues |
Menopausal hot flushes (genistein-rich isoflavones) Limited Evidence | Modest reduction (15–25%) in hot flush frequency with high-genistein supplements; less or none with low-genistein or whole-soy products | Perimenopausal/postmenopausal women with mild-to-moderate vasomotor symptoms who prefer non-hormonal options | 8–12 weeks for plateau effect; some response by 4 weeks |
Breast cancer recurrence (safety and possible protection) Limited Evidence | Neutral or modestly protective (≈25% lower recurrence in highest vs lowest soy intake cohorts); no signal of harm | Breast cancer survivors choosing whole-soy foods (tofu, soy milk, edamame) at moderate intake | Not a quick endpoint; cohort follow-up over years |
Bone density and fracture risk Mixed Evidence | Small (~1–2%) BMD changes in some trials; no fracture-prevention evidence | Postmenopausal women already taking soy for other reasons who get incidental bone benefit | 6–12 months in trials; clinical relevance unclear |
LDL cholesterol reduction (soy protein)
- Effect
- LDL-C −4.76 mg/dL (≈3.2%); total cholesterol −6.41 mg/dL (≈2.8%) at 25 g/day soy protein
- Best fit
- Adults with borderline-elevated LDL who can sustain ~25 g/day soy protein as part of a plant-forward diet
- Time
- ≈6 weeks to see effect; sustained as long as intake continues
Menopausal hot flushes (genistein-rich isoflavones)
- Effect
- Modest reduction (15–25%) in hot flush frequency with high-genistein supplements; less or none with low-genistein or whole-soy products
- Best fit
- Perimenopausal/postmenopausal women with mild-to-moderate vasomotor symptoms who prefer non-hormonal options
- Time
- 8–12 weeks for plateau effect; some response by 4 weeks
Breast cancer recurrence (safety and possible protection)
- Effect
- Neutral or modestly protective (≈25% lower recurrence in highest vs lowest soy intake cohorts); no signal of harm
- Best fit
- Breast cancer survivors choosing whole-soy foods (tofu, soy milk, edamame) at moderate intake
- Time
- Not a quick endpoint; cohort follow-up over years
Bone density and fracture risk
- Effect
- Small (~1–2%) BMD changes in some trials; no fracture-prevention evidence
- Best fit
- Postmenopausal women already taking soy for other reasons who get incidental bone benefit
- Time
- 6–12 months in trials; clinical relevance unclear
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
LDL cholesterol reduction (soy protein)
Supplement benefitSoy protein at roughly 25 g/day modestly lowers LDL and total cholesterol. The Blanco-Mejia/Jenkins 2019 meta-analysis of 43 trials (2,607 participants), commissioned in response to the FDA's review of the soy heart-health claim, found LDL-C dropped 4.76 mg/dL and total cholesterol 6.41 mg/dL (about 3–4%) at a median 25 g/day dose over a median 6 weeks. The effect is modest but consistent across decades of trials — the FDA ultimately kept the qualified heart health claim.
Bottom line: A real but modest LDL drop. Useful as part of a portfolio diet, not as a statin alternative.
Menopausal hot flushes (genistein-rich isoflavones)
Supplement benefitEvidence is genuinely mixed. The 2013 Lethaby Cochrane review (43 RCTs, 4,364 women) concluded there was 'no conclusive evidence' that phytoestrogen supplements reduce hot flush frequency or severity overall — but flagged that high-dose genistein (>30 mg/day) consistently reduced hot flush frequency and warranted further investigation. The Taku 2012 meta-analysis confirmed this dose-response: supplements with >18.8 mg genistein were more than twice as effective as lower-genistein products. Effect is real but modest, slower in onset than HRT, and depends on getting enough genistein.
Bottom line: Worth a 12-week trial of a high-genistein isoflavone supplement if you want a non-hormonal option. Don't expect HRT-level relief.
Evidence is mixed
Cochrane 2013 found no overall benefit, but a subset of trials using high-genistein (>30 mg/day) extracts showed consistent reduction. Trial heterogeneity is substantial — total isoflavone content alone doesn't predict response; genistein dose does.
Breast cancer recurrence (safety and possible protection)
Modern observational and intervention data are reassuring, contrary to the older 'estrogenic = dangerous' framing. The Fritz 2013 systematic review concluded moderate soy food intake does not increase breast cancer risk and may modestly reduce recurrence. The Shanghai Breast Cancer Survival Study and the LACE cohort found similar or lower recurrence rates with higher soy intake. The hesitation centers on high-dose isolated genistein supplements in tamoxifen users, where rodent and cell-culture data show tamoxifen antagonism — but human clinical-outcome confirmation is lacking.
Bottom line: Whole-soy foods are safe and possibly protective in survivors. Be cautious with isolated high-dose isoflavone supplements, especially on tamoxifen.
Evidence is mixed
MSKCC and several oncology bodies still flag preclinical tamoxifen and aromatase-inhibitor antagonism with high-dose genistein. Human cohort data do not show harm, but isolated high-dose supplements are less reassuring than whole-food intake.
Bone density and fracture risk
Mechanism onlySoy isoflavones have weak estrogen-receptor-beta activity that mechanistically could preserve bone. Trials show small (~1–2%) BMD improvements in postmenopausal women over 6–12 months, but with high heterogeneity. No fracture-outcome trial has confirmed clinical benefit. Calcium, vitamin D, weight-bearing exercise, and pharmacotherapy when indicated remain the bone-density mainstays.
Bottom line: Possible small biomarker effect; don't rely on it for bone protection.
How to take it
What to track
Bottom line: For LDL, aim for ~25 g/day soy protein replacing animal protein. For hot flushes, pick a supplement with ≥30 mg/day genistein and give it 12 weeks. Always separate from levothyroxine.
5 commercial forms
Compare the main delivery options and what they’re best suited for.
Whole soy foods (tofu, tempeh, edamame, soy milk)
Best evidence baseThe form used in the cohort studies that found neutral-to-protective breast cancer and cardiovascular outcomes. Naturally contains protein, isoflavones, fiber, and other phytochemicals together. Most adaptable to regular dietary use.
Standard intake reference for population studies.
Soy protein isolate
Cholesterol-focusedConcentrated protein with most carbs and fiber removed. ~90% protein by weight. The form used in the FDA-reviewed cholesterol trials. Common in protein powders and meat substitutes.
Highly bioavailable; isoflavone content varies by processing.
Soy isoflavone supplement (capsule)
Menopausal useStandardized extract delivering 40–80 mg total isoflavones per dose. Check the genistein content — Cochrane data suggest ≥30 mg/day genistein is needed for hot-flush effect.
Bypasses the protein and matrix; isoflavone-only.
Genistein-enriched extract (e.g., 54 mg pure genistein/day)
Strongest menopause signalNewer products standardize to high genistein content based on the trials that showed consistent hot-flush reduction in Lethaby's Cochrane review. Higher cost than mixed-isoflavone products.
Same isoflavone-only profile; higher genistein dose.
Soy sauce, miso, fermented soy
Low isoflavone contentTyramine-rich and high-sodium. Fermentation reduces some isoflavone content. Fine as condiments but not a useful source of isoflavones or therapeutic soy protein.
Low isoflavone yield; mostly a flavor source.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Soy allergy can cause anaphylaxis in sensitized individuals — common in children with peanut/legume allergies; carry an EpiPen if previously sensitized.
Case reports of hypothyroidism with high isoflavone intake, especially in people with marginal iodine status — check thyroid function if symptoms develop.
Tamoxifen and aromatase-inhibitor antagonism is shown in lab/animal models with high-dose genistein. Clinical relevance in humans is unproven, but discuss high-dose isolated isoflavone supplements with oncology before starting.
Who should avoid it
- People with known soy allergy or severe peanut allergy with cross-reactivity.
- People on tamoxifen or aromatase inhibitors considering high-dose isolated isoflavone supplements without oncology input.
- Anyone with hypothyroidism who cannot reliably separate soy intake from levothyroxine by 4 hours.
Pregnancy & breastfeeding
Whole soy foods are considered safe at typical dietary levels in pregnancy. Concentrated isoflavone supplements at supraphysiological doses haven't been adequately studied in pregnancy and aren't recommended. There's no high-quality data linking moderate soy food intake to adverse pregnancy outcomes.
Bottom line: Whole-soy foods are very safe for most adults. Concentrated isoflavone supplements deserve more caution — particularly with tamoxifen, aromatase inhibitors, or thyroid medication.
Interactions
Soy protein and isoflavones can reduce levothyroxine absorption; separate doses by at least 4 hours. Recheck TSH 6–8 weeks after starting regular soy intake.
Genistein antagonizes tamoxifen in cell-culture and rodent studies; human clinical-outcome data are lacking but the signal is strong enough that high-dose isolated isoflavone supplements should be discussed with oncology. Whole-soy food intake appears safe based on cohort data.
Genistein can increase aromatase expression in MCF-7 cell lines, potentially blunting drug effect. Same caution as tamoxifen: whole-food intake appears safe; high-dose supplements warrant oncology input.
Sporadic case reports of altered INR with high soy intake; clinically meaningful in only a minority of patients. Monitor INR closely when starting or stopping regular soy consumption if on warfarin.
Fermented soy products contain tyramine; can contribute to hypertensive episodes in patients on MAO inhibitors. Limit fermented soy if on MAOIs.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance — a complement to the narrative section above.
See all 1 Soy interaction →Food sources
| Food | Amount | %DV |
|---|---|---|
| Soy protein isolate (1 scoop) | 28 g (25 g protein, ~25 mg isoflavones) | — |
| Tempeh, cooked | ½ cup (31 g protein, 35 mg isoflavones) | — |
| Edamame, shelled, cooked | 1 cup (18 g protein, 18 mg isoflavones) | — |
| Tofu, firm | ½ cup (22 g protein, 31 mg isoflavones) | — |
| Soy milk, plain | 1 cup (8 g protein, 6 mg isoflavones) | — |
| Soy nuts, roasted | ¼ cup (15 g protein, 40 mg isoflavones) | — |
| Miso paste | 1 tbsp (2 g protein, 7 mg isoflavones) | — |
| Natto | ½ cup (15 g protein, 41 mg isoflavones) | — |
Soy protein isolate (1 scoop)
- Amount
- 28 g (25 g protein, ~25 mg isoflavones)
- %DV
- —
Tempeh, cooked
- Amount
- ½ cup (31 g protein, 35 mg isoflavones)
- %DV
- —
Edamame, shelled, cooked
- Amount
- 1 cup (18 g protein, 18 mg isoflavones)
- %DV
- —
Tofu, firm
- Amount
- ½ cup (22 g protein, 31 mg isoflavones)
- %DV
- —
Soy milk, plain
- Amount
- 1 cup (8 g protein, 6 mg isoflavones)
- %DV
- —
Soy nuts, roasted
- Amount
- ¼ cup (15 g protein, 40 mg isoflavones)
- %DV
- —
Miso paste
- Amount
- 1 tbsp (2 g protein, 7 mg isoflavones)
- %DV
- —
Natto
- Amount
- ½ cup (15 g protein, 41 mg isoflavones)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
References by claim
LDL cholesterol reduction (soy protein)
Menopausal hot flushes (genistein-rich isoflavones)
Breast cancer recurrence (safety and possible protection)
Fritz et al., 2013 — Soy, red clover, isoflavones and breast cancer systematic review — PMC — Curr Oncol (2013) link
Track Soy with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.